Association of α-synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset

Movement Disorders

Volumn 21, Issue 4, 2006, Pages 534-539

  Hadjigeorgiou, Georgios M ^a   Xiromerisiou, Georgia ^a,b   Gourbali, Vanessa ^a   Aggelakis, Kostantinos ^a   Scarmeas, Nikolaos ^a,c   Papadimitriou, Alexandros ^a   Singleton, Andrew ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Department of Medicine   (United States)

Author keywords

synuclein; Association study; Parkinson's disease; Rep1, polymorphism

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN REP 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOME ANALYSIS; GENOTYPE; GREECE; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SURVIVAL ANALYSIS;

EID: 33646249380     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20752     Document Type: Article

References (31)

1. Dawson TM, Dawson VL. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J Clin Invest 2003;111:145-151.
2. Hardy J, Cookson MR, Singleton A. Genes and parkinsonism. Lancet Neurol 2003;2:221-228.
3. Huang Y, Cheung L, Rowe D, Halliday G. Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev 2004;46:44-70.
4. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
5. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997;388: 839-840.
6. Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 1999;52:651-654.
7. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18:106-108.
8. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
9. Tan EK, Khajavi M, Thomby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000;55:533-538.
10. Chiba-Falek O, Nussbaum RL. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mot Genet 2001;10:3101-3109.
11. Parsian A, Racette B, Zhang ZH, et al. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology 1998;51:1757-1759.
12. Kruger R, Vieira-Saecker AM, Kuhn W, et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/ apolipoprotein E genotype. Ann Neurol 1999;45: 611-617.
13. Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 2000;54:1195-1198.
14. Khan N, Graham E, Dixon P, et al. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol 2001;49:665-668.
15. Izumi Y, Morino H, Oda M, et al. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan. Neurosci Lett 2001;300:125-127.
16. Farrer M, Maraganore DM, Lockhart P, et al. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001;10:1847-1851.
17. Mizuta I, Nishimura M, Mizuta E, Yamasaki S, Ohta M, Kuno S. Meta-analysis of alpha synuclein/NACP polymorphism in Parkinson's disease in Japan. J Neurol Neurosurg Psychiatry 2002;73:350.
18. Spadafora P, Annesi G, Pasqua AA, et al. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy. Neurosci Lett 2003; 351:75-78.
19. Tan EK, Tan C, Shen H, et al. Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett 2003;336:70-72.
20. Mellick GD, Maraganore DM, Silburn PA. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease. Neurosci Lett 2005;375:112-116.
21. Pals P, Lincoln S, Manning J, et al. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004;56: 591-595.
22. Tan EK, Chai A, Teo YY, et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. Neurology 2004;62:128-131,
23. Chiba-Falek O, Touchman JW, Nussbaum RL. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet 2003; 113:426-431.
24. Xia Y, Rohan de Silva HA, Rosi BL, et al. Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Ann Neurol 1996;40:207-215.
25. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
26. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-309.
27. Zareparsi S, Camicioli R, Sexton G, et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet 2002;107:156-161.
28. Kruger R, Menezes-Saecker AM, Schols L, et al. Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease. NeuroReport 2000;11:2439-2442.
29. Westberg L, Hakansson A, Melke J, et al. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease. Psychoneuroendocrinology 2004;29:993-998.
30. Hakansson A, Westberg L, Nilsson S, et al. Investigation of genes coding for inflammatory components in Parkinson's disease. Mov Disord 2005;20:569-573.
31. Ott J. Association of genetic loci: replication or not, that is the question. Neurology 2004;63:955-958.